You searched for "EAONO"

49 results found

The costs of applying to ENT specialty training

Training doctors is costly. In the UK, medical school costs an estimated £230,000 made up of £163,000 in government grants and £65,000 in student loans [1]. Repayment of the student loan begins once the graduate earns above a certain threshold,...

Assessment of genetic disorders: congenital sensorineural hearing loss

Severe or profound sensorineural hearing impairment (SNHI) is a common birth defect, affecting approximately 1 in 1000 newborns [1]. SNHI may result from environmental causes or have a genetic basis. The genetic causes can be further subdivided into non-syndromic (isolated...

The European Board Exam in Otorhinolaryngology-Head and Neck Surgery (EBEORL-HNS) and the benefits it will have on your career

Ulrik Pedersen, Chairman European Board Examination in Otorhinolaryngology-Head and Neck Surgery, and Shawkat Alaa Shawkat Abdulrahman, Rhinology Consultant Tallaght Teaching Hospital, Dublin, outline the history and format of the EBEORL–HNS and demonstrate the huge benefits gained from the qualification with...

In conversation with Professor Charles Liberman

Just before I left Cambridge to work with the Hearing Sciences group in Nottingham, I spent a very happy hour alone in the company of Professor Charles Liberman, the Director of the Eaton-Peabody Laboratories based at the Massachusetts Eye and...

Welcome to ERS2023

For ERS2023, for the first time, the ERS board elected a scientific president to chair the scientific programme committee. The ERS board is very happy that Prof Paolo Castlenuovo was willing to take this task upon himself. Here he outlines...

New RSM presidents preview the year ahead

Professor Patrick Axon, President of the UK’s Royal Society of Medicine Otology Section and Michelle Wyatt, incoming President of the section of Laryngology and Rhinology, look forward to the year ahead.

Harnessing head and neck cancer genomics for personalised medicine

Luc Morris updates us on the future of cancer diagnosis and treatment, which lies in “personalised oncology”, where specific molecular alterations of each tumour will be identified, and matched with actionable alterations in existing therapies, ushering in the era of...

Genomic testing for deafness and its implications

Gene therapies for hearing loss are rapidly advancing and will be transitioning to clinical practice. Here, the authors explain why clinicians involved in managing these disorders need to be aware of these advances. Genomic testing in England was significantly reconfigured...

Branchio Oto Renal syndrome

Branchio Oto Renal Syndrome (BOR) is an autosomal dominant disorder with branchial, otologic and renal manifestations. The presence of clinical signs varies among and within affected families. Three causative genes for BOR syndrome have been reported thus far: EYA1, SIX1...

Radiology of referred otalgia

Otalgia is a common presenting complaint to Ear Nose and Throat Departments. Otalgia is either primary or secondary (referred) [1]. Referred otalgia is a ‘red flag’ symptom and can be a diagnostic challenge for clinicians and radiologists as the pathology...

Thyroid cancer – the last decade

Professor Ashok Shaha describes the evolution in the treatment of thyroid cancer that he has witnessed over the last decade and the invaluable progress made by himself and others, from their contributions to staging systems and guidelines. Nuances and paradigm...

Less than full time training: the best of both worlds!

Every one of us can feel the pressures of competing interests of everyday life and commitment to our careers. This can be even more difficult when bringing up a young family, especially when we have had to move away from...